Remove 2016 Remove Atrial Fibrillation Remove Outcomes
article thumbnail

Comparing Efficacy and Safety Between Patients With Atrial Fibrillation Taking Direct Oral Anticoagulants or Warfarin After Direct Oral Anticoagulant Failure

Journal of the American Heart Association

BackgroundAn increased risk of recurrent stroke is noted in patients with atrial fibrillation despite direct oral anticoagulant (DOAC) use. 0.45] for rivaroxaban), and a 69% to 83% reduced risk of net composite outcomes (aHR, 0.25 [95% CI, 0.18–0.35] We identified 3759 patients with DOAC failure. 0.41] for rivaroxaban).ConclusionsIn

article thumbnail

Combination of early rhythm control and healthy lifestyle on the risk of stroke in elderly patients with new-onset atrial fibrillation: a nationwide population-based cohort study

Frontiers in Cardiovascular Medicine

Background The impact of early rhythm control (ERC) combined with healthy lifestyle (HLS) on the risk of ischemic stroke in elderly patients with atrial fibrillation (AF) remains unaddressed. Objective To evaluate the impact of combined ERC and HLS on the risk of stroke in elderly patients with new-onset AF.

article thumbnail

Abstract TP230: Atrial Fibrillation and Short-Term Outcomes After Cancer-Related Ischemic Stroke

Stroke Journal

Introduction:Atrial fibrillation (AF) and cancer are both independently associated with worse outcomes in patients with acute ischemic stroke. Few studies have evaluated the impact of AF on outcomes of cancer-related stroke. The primary outcome was in-hospital mortality. The primary exposure was a diagnosis of AF.

Cancer 40
article thumbnail

Effectiveness, utilisation and cost associated with implantable loop recorders versus external monitors after ischaemic or cryptogenic stroke

Open Heart

Objective Implantable loop recorders (ILRs) are increasingly used for long-term rhythm monitoring after ischaemic and cryptogenic stroke, with the goal of detecting atrial fibrillation (AF) and subsequent initiation of oral anticoagulation to reduce risk of adverse clinical outcomes.

Stroke 73
article thumbnail

Abstract WP246: CHA2DS2-VASC Score Predicts Outcomes After a Stroke or Transient Ischemic Attack

Stroke Journal

Introduction:The CHA2DS2-VASC score is used to predict stroke in people with atrial fibrillation (AF). Outcomes included health-related quality of life (HRQoL) at 90-180 days post-stroke/TIA; and all-cause mortality and hospital readmissions (all-cause, cardiovascular disease) within 1 year post-stroke/TIA.

Stroke 40
article thumbnail

PO-04-087 DOES THE PRIOR PLACEMENT OF A LEFT ATRIAL APPENDAGE OCCLUSION (LAAO) DEVICE HAVE AN IMPACT ON PERI-PROCEDURAL COMPLICATIONS AND IN-HOSPITAL OUTCOMES IN PATIENTS UNDERGOING RADIOFREQUENCY ABLATION FOR ATRIAL FIBRILLATION (AF) ? INSIGHTS FROM NATIONAL INPATIENT SAMPLE: 2016-2020

HeartRhythm

This led to the development of LAAO devices which serve to occlude the left atrial appendage, a small portion of the left atrium where up to 91% of the AF-related thrombi form. Oral Anticoagulation, often necessary for the treatment of patients with AF presents a problem for patients at high risk for bleeding.

article thumbnail

Clinical characteristics and prognosis of patients with isolated cardiac sarcoidosis: Insights from the ILLUMINATE?CS study

European Journal of Heart Failure

Among 475 patients with cardiac sarcoidosis, 119 (25.1%) were isolated cardiac sarcoidosis (iCS) based on the 2016 Japanese Circulation Society criteria. iCS was diagnosed according to the 2016 Japanese Circulation Society (JCS) guidelines. months, 141 primary outcomes (29.7%) occurred. During a median follow-up of 42.3